AFP and hepatocellular carcinoma: Another study of patients who underwent transarterial chemoembolization for HCC (CP class A/B: 45.9%/54.1%) revealed GNRI <98, tumor number ≥ 2, tumor size ≥5 cm, TACE times <3, and alpha-fetoprotein ≥400 as independent risk factors for poor prognosis (32).